您好,欢迎来到上海士研管理咨询有限公司
产业峰会 演讲局 专家智库服务 峰会活动服务 整合营销服务
  • 产业峰会:
    以专业团队对产业和市场客观详实地调研为前提,拥有战略性、系统性、全球性的基因,汇集了领导者关注的热点话题与领袖代表,为您提供“一站式”的对话、分享、社交平台!
  • 演讲局:
    致力于为全球企业和机构提供主题演讲家、高管大师班、董事会顾问,每项服务都提供了一种更深入、更具互动性的体验,尤其是针对较小的精选受众和关键个人。我们拥有最具影响力的商业领袖和顶级专家的资源,他们是各自领域的最杰出的代表。我们的团队由经验丰富的演讲和活动经理组成,我们注重建立长期而深入的伙伴关系。
  • 专家智库服务:
    中国领先的行业专家知识信息服务供应商,为需要专业洞见的商业决策者匹配具有一手经验的行业专家,助力他们以更加明确的目标和坚定的信心做出决策。我们有60万余名专家顾问遍布二十多个行业,而且每天还在增加!
  • 峰会活动服务:
    致力于成为全球最专业的产业峰会活动提供商,为企业和机构的产业性峰会活动提供一站式专业服务,包括调研策划、定制邀请、营销推广、运营组织、项目管理、直播与数字化会议等,每项服务都由经验丰富的专业团队匹配长期沉淀的产业资源予以卓越执行,我们注重建立长期而深入的伙伴关系。
  • 整合营销服务:
    致力于成为全球领先的2B营销服务机构,聚焦产业高端活动、内容、渠道的建设与沉淀,为客户提供一站式整合营销解决方案,助力企业线上线下获客与品牌筑造。我们深信专业团队匹配产业资源带来卓越执行,我们注重建立长期而深入的伙伴关系。
嘉宾信息
发布时间: 2021 - 04 - 07
点击次数: 0
所属职位: 总经理
所属公司: 上海华奥泰生物药业股份有限公司
个人简介:
Xiang Yang Zhu Ph.D.CEO. Shanghai Huaota Biopharmaceutical Co., Ltd.  Biography Dr. Zhu is an expert in antibody drug discovery and process development with more than 20 years of industrial experience. He has extensive experience in antibody drug discovery, process development, and manufacture facility construction. Dr. Zhu is the CEO for both Huaota Biopharm and Huabo Biopharm (members of Huahai Pharm), leads its global biotherapeutic research. He led the team with 6 products in different clinic trails (two phase III, two phase II, two phase I) and more than ten pipelines in pre-clinics. Prior to join Huahai, he worked at Boehringer Ingelheim in different function areas at multiple locations ( Ridgefield, USA; Biberach, Germany; and Shanghai, China). He led and engaged in over 20 global BI biological research projects, is the inventor for Raskizumab; Dr. Zhu obtained his PhD in microbiology and immunology from the University of Illinois at Chicago .    朱向阳博士 上海华奥泰生物药业股份有限公司总经理      朱向阳博士,中组部“千人计划”,“浙江省领军人才”,是生物制药研发和工艺开发方面的专家,在单抗筛选和鉴定,双靶点抗体的工程改造,细胞株的建立,工艺开发, 技术转移, 中试厂房的设计和建设等领域拥有丰富经验。 朱向阳博士目前是上海华奥泰生物股份有限公司总经理,负责公司的全球生物制药研发,带领团队完成6个项目的中美临床申报(目前2个Ⅲ期、2个‖期,2个Ⅰ期)同时有10多个早期研发项目,包括双功能抗体和ADC项目 。朱向阳博士曾长期在勃林格殷格翰(BI)的不同领域和地点工作(美国,德国,中国),领导和参与了20多个单抗或双靶点抗体项目的研究,是Risankizumab早期项目负责人和发明人,Risankizumab已在美国和日本上市。朱向阳在伊利诺伊大学获得免疫学博士学位。
发布时间: 2021 - 04 - 07
点击次数: 0
所属职位: 副总经理(生物制药)
所属公司: 齐鲁生物制药有限公司
个人简介:
刘丁目前担任齐鲁生物制药有限公司副总经理,负责生物制药生产工艺技术和大规模厂房设计建设。 她拥有20多年生物制药工业界全方位经验,从早期基因克隆筛选,成药性研究,与CMC工艺开发验证,技术转移,到厂房设计,工艺自动化,精益运营,GMP合规性,和大规模商业化生产。她作为CMC/项目负责人参与了多个创新抗体药物与生物类似药的成功上市。 刘丁曾在美国GSK/HGS工作超过18年,具有多年2万升罐大规模生产的一线经验。2014年回国后前后在药明生物和百济神州负责GMP生产,工艺开发与验证,技术转移,生产科技,供应链管理,以及各种生物药厂房设计建设(不锈钢,一次性与模块化)。 Ding (Judie) Liu is currently Deputy General Manager of Qilu BioPharma responsible for BioPharma manufacturing process and technology.  She has more than 20 years of broad experiences in biopharmaceutical industry, from early gene discovery and cloning, pre-clinical studies, to CMC process development and validation, tech transfer, to facility design, process automation, operation excellence, GMP compliance,and large scale commercial manufacturing.  As the CMC/Project leader, she and her teams have successfully brought multiple innovated antibody drugs and biosimilar to the market. Judie has been working at GSK/HGS for over 18 years with many years hands-on experiences in 20000L-scale manufacturing.  After returning to China, she has been worked at Wuxi Biologics and BeiGene in charge of GMP manufacturing, process development and validation, tech transfer, manufacturing science and technology, supply chain management, and biologics facility design (including stainless steel, single use, and modular).
发布时间: 2021 - 04 - 16
点击次数: 0
所属职位: 董事长兼首席执行官
所属公司: 上海复星医药(集团)股份有限公司
个人简介:
吴以芳于 2004 年 4 月加入复星医药,2016年起至2020年10月担任复星医药总裁兼CEO,2020年10月起至今担任复星医药董事长兼CEO。吴以芳同时还担任江苏省人大代表、中国药品监督管理研究会常务理事、中国医药新闻信息协会副会长、中国医药企业管理协会副会长、中国化学制药工业协会副会长、中国非处方药物协会副会长。Mr. William Wu, joined Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in April 2004 and is currently the chairman of the board and Chief Executive Officer. Mr. Wu has over 30 years of experience in the pharmaceutical industry. Mr. Wu is currently the Representative of the 13th National People’s Congress of Jiangsu Province, as well as Executive member of China Society for Drug Regulation, Vice Chairman of China News of Drug Information Association; Vice Chairman of Chinese Pharmaceutical Enterprises Association; Vice Chairman of China Nonprescription Medicines Association; Vice Chairman of China Pharmaceutical Industry Association; Vice Chairman of China Pharmaceutical Enterprises Association; Vice Chairman of China Nonprescription Medicine Association.
发布时间: 2021 - 04 - 16
点击次数: 0
所属职位: 董事、副总经理
所属公司: 华北制药集团有限责任公司
个人简介:
大学本科学历,研究生学位,就职于华北制药集团有限责任公司,正高级工程师,担任公司党委常委、董事、副总经理,主要从事制药生产、运营管理。担任中国化学制药行业协会副秘书长、抗生素专业委员会秘书长、河北省医药行业协会环保专业委员会主任、河北省微生物学会副理事长、河北省环保联合会副理事长等社会职务。牵头组织国家高技术研究发展计划(863计划)重点项目《高纯度青霉素研究》等多项国家、省市科研项目,现担任国家“十三五”制药行业水专项《制药行业全过程水污染控制技术集成与工程实证》 课题负责人。Mr. Zhang yuxiang is in charge of production and operation management in North China Pharmaceutical Group Co., Ltd as CPC standing committee, Director and Vice general manager, his professional title is senior engineer. He also carries out social duties as deputy secretary general of China Pharmaceutical Industry Association, secretary general of Antibiotics Committee, chief of  Environment Protection Committee of Hebei Pharmaceutical Profession Association, vice president of Hebei Microbiology Society, vice president of Hebei Environment Protection Federation etc. He has led and organized many state and local scientific research projects, such as Research on High Purity Penicillins, which is a key project in National High Technology Research and Development Program (China’s 863 Program). Mr. Zhang now leads the specific research subject on Integration & Engineering Demonstration of Water Pollution Control Technology Throughout Pharmaceutical Process.
微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务